CN103907952A - Health-care ostrich meat sausage - Google Patents
Health-care ostrich meat sausage Download PDFInfo
- Publication number
- CN103907952A CN103907952A CN201410170801.2A CN201410170801A CN103907952A CN 103907952 A CN103907952 A CN 103907952A CN 201410170801 A CN201410170801 A CN 201410170801A CN 103907952 A CN103907952 A CN 103907952A
- Authority
- CN
- China
- Prior art keywords
- kilogram
- ostrich meat
- care
- health
- ostrich
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000272534 Struthio camelus Species 0.000 title claims abstract description 36
- 235000019690 meat sausages Nutrition 0.000 title abstract 6
- 235000013372 meat Nutrition 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 33
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 241000110637 Cuscuta chinensis Species 0.000 claims abstract description 11
- 244000215777 Plumeria rubra Species 0.000 claims abstract description 11
- 235000013087 Plumeria rubra Nutrition 0.000 claims abstract description 11
- 244000203593 Piper nigrum Species 0.000 claims abstract description 7
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 7
- 235000013614 black pepper Nutrition 0.000 claims abstract description 7
- 235000008397 ginger Nutrition 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000001931 piper nigrum l. white Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 7
- 229960002675 xylitol Drugs 0.000 claims abstract description 7
- 235000010447 xylitol Nutrition 0.000 claims abstract description 7
- 239000000811 xylitol Substances 0.000 claims abstract description 7
- 241000195947 Lycopodium Species 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 19
- 230000036541 health Effects 0.000 claims description 14
- 210000000936 intestine Anatomy 0.000 claims description 13
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 6
- 235000020097 white wine Nutrition 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 23
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 210000004072 lung Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 3
- 241000195954 Lycopodium clavatum Species 0.000 abstract 2
- 244000003187 Juncus effusus Species 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 230000001276 controlling effect Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 25
- 239000003814 drug Substances 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 235000015278 beef Nutrition 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 235000013580 sausages Nutrition 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 235000015277 pork Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 229960004580 glibenclamide Drugs 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000014122 turkey meat Nutrition 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
- A23L13/52—Comminuted, emulsified or processed products; Pastes; Reformed or compressed products from poultry meat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a health-care ostrich meat sausage. The invention relates to the health-care ostrich meat sausage capable of preventing and treating hyperglycemia. The health-care ostrich meat sausage capable of preventing and treating the hyperglycemia is characterized by comprising following raw materials: 5-6kg of ostrich meat, 0.5-1kg of lycopodium clavatum fluid extract dried powder, 0.14kg of salt, 0.2kg of xylitol, 200ml of white spirit, 0.03kg of essence, 0.04kg of white pepper powder and 0.04kg of bruised ginger. According to the ostrich meat sausage, plumeria rubra, cuscuta chinensis, poria cocos, ophiopogon japonicus and juncus effusus are used for regulating the balance of the five internal organs including the heart, the liver, the spleen, the lung and the kidney, dispersing blood stasis, and removing turbidity and thirsty; the lycopodium clavatum is used for relaxing the muscles, stimulating the blood circulation, and tonifying qi and dredging collaterals, so as to realize the aim of lowering the blood sugar; the ostrich meat has a delicious taste, and is high in protein, low in fat, low in cholesterol and low in heat; the health-care ostrich meat sausage can be used for properly supplementing nutrition when being eaten usually and can also be used for preventing and controlling the hyperglycemia.
Description
Technical field
The present invention relates to a kind of health care ostrich meat intestines, especially a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia.
Background technology
Forming good dietetic life custom is one of effective way of actively preventing and treating hyperglycaemia: must keep on a diet, avoid high confectionery thing, as various candies, sweet food. reduce fatty absorption, avoid greasy and fatty high food. select high fiber food, as coarse food grain, the vegetables that fibre-bearing is high. have meal at regular time and quantity, many meal on a small quantity; Guarantee the absorption of protein, protein is supplied with first-selected good protein, as milk, egg, lean meat etc.
Diabetes, in the traditional Chinese medical science, are mainly that the five internal organs are weak due to the plain body deficiency of Yin, multiple because of eating and drinking without temperance, overfeeding delicious food, and disorder of emotion, labor is wanted excessively, and causes deficiency of kidney-YIN, and lung stomach is scorching; Interpretation of the cause, onset and process of an illness emphasis is that the deficiency of Yin is scorching, and take the deficiency of Yin as this, scorching is mark; With the passing of time disease prolongs, yin deficiency affecting yang, deficiency in both YIN and YANG; The deficiency of Yin is scorching, and the bright liquid in consumption Tianjin makes blood viscous, the not smooth stasis of blood that forms of blood; Yin deficiency affecting yang, the deficiency of yang is cold solidifying, also can cause sun in hemostasis.
The pure red muscle of the fresh and tender lubricious genus of ostrich meat, juice multi-flavor is fresh, and mouthfeel is good, free from extraneous odour, and there is high protein, low fat, low cholesterol, feature low in calories.Its unit fat content is only 1/10th of beef, pork, but the content of its iron, calcium, zinc, selenium etc. is all higher than general meat, also contains the amino acid of 27 kinds of needed by human.Ostrich meat absorption easy to digest, is applicable to modern's meals trend.Ostrich meat is nutritious, has high nutritive value, and quality is better than beef.The intramuscular fat content that ostrich meat is extremely low is one of its marketing focus in the market, thereby for hope control body weight and to avoid the people of coronary heart disease be most suitable.For example general sheep, the flesh of fish all contain higher cholesterol and fat, and for fear of obesity with produce cardiovascular and cerebrovascular disease, some have to control and eat meat.The cholesterol level of the cholesterol level of ostrich meat and turkey meat and beef is suitable, between containing 57 milligrams to 65~68 milligrams in every 100 grams of tissues.Ostrich meat fat content is 1/3rd of beef, is 1/6th of chicken; Calcium content is 3 times of beef, is 7 times of chicken; Iron content is 5 times of beef, is 7 times of chicken; Zinc content is 3 times of beef, is 6 times of chicken.
Prior art is not applied the preparation of ostrich meat, lycopodium calvatum and is prevented and treated the health care ostrich meat intestines of hyperglycaemia, and the single and health care of taste has its limitation.As the number of patent application of announcing in the Chinese patent information centre invention that is 02158509.1---containing selenium seed of Job's tears pork sausages, this disclosure of the invention a kind of containing selenium seed of Job's tears pork sausages, with component be: coixlacrymajobi powder 20%, pork 70%, mould tea powder 10% is made minced pork, fills with into casing after seasoning, makes bowel lavage; There is strengthening the spleen and stomach, beneficial face, excreting dampness, except the function of numbness, particularly containing selenium element, can strengthen the immunity of human body, effectively removes the multiple focus of human body, balance bodily fuctions, instant; This invention health care has its advantage, but also has weak point.
Summary of the invention
In order to solve prior art problem, the object of the invention is to provide a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia.
Technical scheme: a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia, comprise the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first ostrich meat chopping is made to meat stuffing, then other batching is mixed thoroughly, pour in meat stuffing and grab and mix pasty state, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, mono-of every 18CM, the encapsulation of two tying; 3. above finished product is put into boiling slaking sterilization in container, cooling.
As optimization, a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia of the present invention, comprise the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Lycopodium calvatum, toil temperature, expelling wind and clearing away cold, dehumidifying are subsided a swelling, are stimulated the circulation of the blood and cause the muscles and joints to relax." Hunan medicine will " records lycopodium calvatum: sweet, flat.Nontoxic, enter the heart, kidney two warps, relax the muscles and stimulate the blood circulation, invigorating qi and dredging collateral.
Frangipanis, cool in nature, taste is sweet, light; Return large intestine, stomach warp, there is effect of moistening lung removing toxic substances, clearing heat and expelling damp, laxation.
Radix Glycyrrhizae taste is sweet, flat.The thoughts of returning home, lung, spleen, stomach warp.Function cures mainly: invigorates the spleen and benefits qi, and clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, the anxious pain of four limbs contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Seed of Chinese dodder acrid-sweet flavor, property is flat, enters liver, kidney two warps.There is tonifying kidney and benefiting sperm, nourish the liver to improve visual acuity, antiabortive effect.
Poria cocos taste is sweet, light, property is flat, be used as medicine there is clearing damp and promoting diuresis, the function of beneficial spleen and stomach, antitoxic heart-soothing and sedative.Modern medicine study: Poria cocos energy enhanced machine body immunity function, pachymaran has significantly antitumor and protect the liver dirty effect.
The tuber of dwarf lilyturf, the micro-sugariness hardship of property, cold, there is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, reinforcing yin essence benefit essence, five viscera settling effect.
Rush, is slightly cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Urinary bladder channel.Effect: promoting diuresis for stranguria; Clearing heart fire.Dark plum acid, puckery, flat, returns liver, spleen, lung, large intestine channel.[function cures mainly] astringes the lung, and puckery intestines, promote the production of body fluid, claming ascaris.For chronic cough of deficiency lung, protracted dysentery laxation, abnormal heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract (" Chinese pharmacopoeia ").
Advantage of the present invention: 1, lycopodium calvatum Xin Wenyi impairment of yin blood of the present invention, therefore adapted frangipanis, Radix Glycyrrhizae are in harmonious proportion, make its institute partially, its taste is glycol, fresh and sweet, has channels sootheing and network vessel quickening, function of promoting blood circulation to disperse blood clots.
2, seed of Chinese dodder tonifying kidney and benefiting sperm, Poria cocos clearing damp and promoting diuresis, beneficial spleen and stomach, the tuber of dwarf lilyturf is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, and rush clearing heart fire, dark plum are quenched one's thirst and are brought down a fever, and more contribute to promoting blood circulation and removing blood stasis hypoglycemic.
3, the present invention is by the balance of frangipanis, the seed of Chinese dodder, Poria cocos, the tuber of dwarf lilyturf, rush conditioning human body-centered liver spleen lung kidney the five internal organs, and stagnation resolvation is pure and impure quenches one's thirst, and relax the muscles and stimulate the blood circulation again, thereby invigorating qi and dredging collateral reaches hypoglycemic object with lycopodium calvatum; Ostrich meat delicious flavour, high protein, low fat, low cholesterol, low in calories, often edible the present invention ostrich meat intestines that keep healthy, can suitably supplement the nutrients, and can prevent and control again hyperglycaemia.
4, Chinese medicine powder of the present invention has significant hypoglycemic activity to adrenaline hyperglycaemia mouse and alloxan hyperglycemia mouse.Each 20 of male and female mice is selected in experiment; Adopt respectively adrenaline and alloxan to set up hyperglycaemia mouse model, then give Chinese medicine powder of the present invention, glibenclamide, insoral and treat and survey blood sugar level.In the hyperglycemia mouse of bringing out at adrenaline, Chinese medicine powder of the present invention can make fasting serum glucose [(16. 58 ± 3. 92) mmol/L] be reduced to (7. 56 ± 2. 63) mmol/L, effect and glibenclamide comparison, no significant difference (P>0.05); In the hyperglycemia mouse of model induced by alloxan, the present invention is reduced to fasting serum glucose [(15. 56 ± 1. 83) mmol/L] (7. 55 ± 1.65) mmol/L, blood sugar reducing function is significantly better than insoral (P<0 05), and causes hypoglycemic side effect without glibenclamide.Conclusion: the present invention can significantly reduce the blood sugar level (P <0. 001) of 2 kinds of modeling animals, and makes blood sugar be down to normal level.
5, Chinese medicine powder of the present invention shows through more than the 60 routine sugared dung patients' that make a definite diagnosis clinical observation on the therapeutic effect, and the present invention has remarkable reduction glycosuria patient's blood sugar level, makes blood sugar recovery normal.
Clinical observation result of the present invention:
1.1 physical data: select the People's Hospital of city outpatient service diabetes B patient 60 examples, be divided at random two groups.Treatment group 30 examples, male 16 examples, female's 14 examples, 30~70 years old age, average (50 ± 1.5) year, the course of disease 6 months~15 years, average (8.0 ± 1.2) year; Control group 30 examples, male 18 examples, female's 12 examples, 29~70 years old age.Two groups of physical data comparing difference not statistically significants (P>0.05), have comparativity.
1.2 case selections: with reference to the World Health Organization's (WHO) diabetes diagnosis in 1999 and somatotype standard [1]: diabetic symptom+random time plasma glucose levels >=11.1mmol/L(200mg/dl).The patient's random packet that meets above-mentioned standard is carried out to observational study, and the patient that part takes traditional Chinese medicine stops former Chinese medicine and includes observation in after 2 weeks, and the patient's to be directly brought into not taking traditional Chinese medicine is observed.Two groups of patients all give diabetes Primary Care, comprise diet control, kinesiatrics and orally-taken blood sugar reducing Western medicine, and hypoglycemic Western medicine adopts melbine, carries out drug usage and dose adjustment according to blood sugar situation.
1.3 methods of treatments: treatment group is taken Chinese medicine powder of the present invention on the basis of taking melbine.Basic side is made up of the composition of raw materials of following weight portion: lycopodium calvatum 10, frangipanis 10, Radix Glycyrrhizae 3, the seed of Chinese dodder 5, Poria cocos 10, the tuber of dwarf lilyturf 5; Every natural gift are taken for three times, each 4 grams.Control group routine is taken melbine.Two groups are consistent in diet control, kinesiatrics, and be 2 months two groups of courses for the treatment of.
1.4 observation index: measure respectively fasting blood-glucose (FPG), postprandial blood sugar (2hBG), glycosylated hemoglobin (HbA1c), FPI (FINS), blood fat (TC, TG, HDL-C, LDL-C) before and after treatment, blood sugar determination of glucose oxidase, insulin is measured with putting the method for exempting from, blood fat is measured with automatic clinical chemistry analyzer, HOMA-IR employing Haffner etc. [3,4] in Homa model, calculate the formula of IR, be HOMA-IR=FPG × FINS/22.5 (FPG unit is mmol/L, and FINS unit is mU/L).
1.5 statistical methods: adopt SPSS 14.0 statistical analysis softwares to carry out statistical procedures.Measurement data adopts t check, enumeration data chi-square criterion.
2 results: before and after two groups of treatments, the variation of FPG, 2hBG, HbAIc, FINS and HOMA-IR refers to table 1.By in table 1, we can see, treat front two groups of patient FPG, 2hBG, HbAlc, FINS, the horizontal comparing difference not statistically significant of HOMA-IR (P>0.05); After treating, two groups of FPG, 2hBG, HbAlc, FINS, HOMA-IR levels have statistical significance (P<0.05 or P<0.01) with the front comparing differences for the treatment of, before treatment group patient's These parameters and treatment, relatively have significant difference (P<0.01).Prompting treatment group and control group all can reduce diabetes blood sugar, but it is more obvious to improve blood sugar with treatment group.
The variation of FPG, 2hBG, HbAlc, FINS and HOMA-IR before and after table 1 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; The rear two groups of FINS for the treatment of and HOMA-IR compare ^P<0.05, ^^P<0.01.
Before and after two groups of patient treatments, the variation of TC, TG, HDL-C, LDL-C is in table 2.From table 2, we can see the front two groups of patients' for the treatment of the horizontal comparing difference not statistically significant of TC, TG, HDL-C, LDL-C (P>0.05); After treatment, TC, TG, HDL-C, the LDL-C level of two groups have significant change, wherein TC, TG, LDL-C level have statistical significance (P<0.05) with the front comparing difference for the treatment of, and relatively have significant difference (P<0.01) before treatment group HDL-C level and treatment.Illustrate that treatment group and control group all can improve diabetic's blood lipid level, and more remarkable with treatment group effect.
The variation of TC, TG, HDL-C, the horizontal content of LDL-C before and after table 2 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; After treatment, two groups of indices are compared ^P<0.05, ^^P<0.01.
The specific embodiment
Embodiment 1: a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia, comprise the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first ostrich meat chopping is made to meat stuffing, then other batching is mixed thoroughly, pour in meat stuffing and grab and mix pasty state, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, mono-of every 18CM, the encapsulation of two tying; 3. above finished product is put into boiling slaking sterilization in container, cooling.
Embodiment 2: a kind of health care ostrich meat intestines of preventing and treating hyperglycaemia, comprise the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Preparation method is with embodiment 1.
Claims (2)
1. prevent and treat health care ostrich meat intestines for hyperglycaemia, it is characterized in that comprising the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
2. prevent and treat health care ostrich meat intestines for hyperglycaemia, it is characterized in that comprising the raw material of following weight: ostrich meat 5-6 kilogram, 0.5-1 kilogram, lycopodium calvatum liquid extract dry powder, 0.14 kilogram of salt, 0.2 kilogram of xylitol, white wine 200ml, 0.03 kilogram, essence, 0.04 kilogram of white pepper powder, 0.04 kilogram, ginger end; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410170801.2A CN103907952A (en) | 2014-04-27 | 2014-04-27 | Health-care ostrich meat sausage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410170801.2A CN103907952A (en) | 2014-04-27 | 2014-04-27 | Health-care ostrich meat sausage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103907952A true CN103907952A (en) | 2014-07-09 |
Family
ID=51034221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410170801.2A Pending CN103907952A (en) | 2014-04-27 | 2014-04-27 | Health-care ostrich meat sausage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103907952A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015020991A (en) * | 2013-07-23 | 2015-02-02 | 株式会社保健科学研究所 | Hyperglycemia inhibitor |
CN104489730A (en) * | 2014-12-23 | 2015-04-08 | 林玉翠 | Ostrich meat sausage for prevention and treatment of tumor |
-
2014
- 2014-04-27 CN CN201410170801.2A patent/CN103907952A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015020991A (en) * | 2013-07-23 | 2015-02-02 | 株式会社保健科学研究所 | Hyperglycemia inhibitor |
CN104489730A (en) * | 2014-12-23 | 2015-04-08 | 林玉翠 | Ostrich meat sausage for prevention and treatment of tumor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102934803B (en) | Health-care crocodile sausage | |
CN102934801B (en) | Health-care deer sausage | |
CN102919874B (en) | Ostrich sausage | |
CN103907957A (en) | Bamboo rat sausage | |
CN103919176A (en) | Lobster meat sausage | |
CN103907952A (en) | Health-care ostrich meat sausage | |
CN102940271A (en) | Camel meat sausage | |
CN103919153A (en) | Healthcare quail sausage | |
CN103907956A (en) | Health horsemeat sausage | |
CN103907963A (en) | Crocodile meat sausage | |
CN103932226A (en) | Venison sausage | |
CN103947925A (en) | Buckwheat porridge | |
CN103919155A (en) | Healthcare pigeon sausage | |
CN102934804B (en) | Rabbit meat sausage | |
CN103919175A (en) | Prawn sausage | |
CN103919162A (en) | Mutton sausage | |
CN103907970A (en) | Whitebait meat balls | |
CN103919161A (en) | Healthcare pork sausage | |
CN102018245A (en) | Formula of pig bone soup with fig and preparation method thereof | |
CN103931772A (en) | Milk tea | |
CN103947916A (en) | Jelly | |
CN103919163A (en) | Ass meat sausage | |
CN102934802A (en) | Health-care peacock sausage | |
CN103919159A (en) | Health camel meat sausage | |
CN103919160A (en) | Health-care rabbit meat sausage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140709 |